You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
American Association for Clinical Chemistry
Better health through laboratory medicine
Home
|
Customer Service
|
Site Map
|
Cart
|
Login
About AACC
Members
Events
Government & Public Affairs
Resource Centers
Professional Development
Publications
AACC Store
>
Members
>
NACB - The AACC Academy
>
NACB Blog
Recent Posts
Should We Still be Performing Fetal Fibronectin Testing in the Clinical Lab?
What is the diagnosis?
Newborn Screening for Severe Combined Immunodeficiency (SCID): Should it be performed?
Are reference change values more useful than population-based reference intervals?
Categories
Cancer and Tumor Markers
Case Study
Clinical Translational Science/Proteomics
CVD/Markers/Risk Factors
Diabetes/Endocrinology
Government Affairs/Patient Safety
Immunology/Infectious Disease
Instrumentation/Technology
Management/Medical Informatics
Molecular Pathology and Genetics
New/Other Disease Markers
Nutrition
POC Testing
Renal/GI/Hepatic
Special Populations
TDM/Toxicology
Archives
Year
: 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
Year
: 2012
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
Year
: 2011
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
RSS Feed
NACB Blog
Managing OGTTs: ACOG versus ADA/NACB
8/30/2011 8:19 AM |
Comments (6)
Recommend (699)
By
Douglas Stickle, PhD
Current standards of medical practice from the American Diabetes Association (ADA) (1) and the parallel guidelines from NACB (2) include relatively straightforward criteria for diagnosis of diabetes. Guidelines also include instructions and interpretations for the oral glucose tolerance test (OGTT)...(
Read More
)
Posted at 8/30/2011 8:19 AM | Tags:
Diabetes/Endocrinology
Has Quantitative Measurement of Fecal Hemoglobin Concentration Come of Age?
8/23/2011 8:06 AM |
Comments (0)
Recommend (1,013)
By
Callum Fraser, PhD
Screening the asymptomatic population for significant colorectal neoplasia, that is, cancer and advanced adenomatous polyps (sometimes called high-risk or significant), has generated significant interest over recent years with national or regional pilots or programs being set up in all over the wor...(
Read More
)
Posted at 8/23/2011 8:06 AM | Tags:
Cancer and Tumor Markers
My Drug Test Showed What?!?
8/16/2011 8:06 AM |
Comments (0)
Recommend (868)
By
Gwen McMillin, PhD
In a clinical laboratory setting, drug testing is most commonly performed to compliment and improve patient care. Drug testing results are used as a tool, along with other clinical data, behavioral monitoring, and self-report, for guiding how a patient is managed, and for assuring that “all is wel...(
Read More
)
Posted at 8/16/2011 8:06 AM | Tags:
TDM/Toxicology
Bloodspots: More to Follow?
8/9/2011 9:24 AM |
Comments (2)
Recommend (770)
By
Douglas F. Stickle, PhD
The American Chemical Society's Chemical & Engineering News recently had a cover story on use of filter paper bloodspots by big pharma, entitled "Drug development: dried blood spots could trump plasma" (1). The article followed two 2010 issues of the journal Bioanalysis that were dev...(
Read More
)
Posted at 8/9/2011 9:24 AM | Tags:
Special Populations
1 - 4
(Hidden) Admin Links
About AACC
|
Members
|
Government & Public Affairs
|
Resource Centers
|
Professional Development
|
Publications
Home
|
Customer Service
|
Site Map
|
AACC Store
|
Login
Contact Us
|
Privacy Policy and Legal Disclaimer
|
Join AACC
©2013 American Association for Clinical Chemistry
1850 K Street, NW Suite 625
Washington, DC 20006
Phone: (800) 892-1400 | Fax: (202) 887-5093